{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T04:25:05Z","timestamp":1784175905127,"version":"3.55.0"},"reference-count":223,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001785","name":"Flinders University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008017","name":"Flinders Medical Centre Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008017","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.biopha.2025.118013","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T15:48:03Z","timestamp":1743176883000},"page":"118013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Current knowledge on the mechanisms underpinning vasculogenic mimicry in triple negative breast cancer and the emerging role of nitric oxide"],"prefix":"10.1016","volume":"186","author":[{"given":"Belete Kassa","family":"Alemu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Tommasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie-Ann","family":"Hulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai","family":"Meyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8699-1412","authenticated-orcid":false,"given":"Arduino A.","family":"Mangoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2025.118013_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biopha.2025.118013_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-071674","article-title":"Advances in systemic therapies for triple negative breast cancer","author":"Leon-Ferre","year":"2023","journal-title":"BMJ 381"},{"issue":"3","key":"10.1016\/j.biopha.2025.118013_bib3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/1758834014521110","article-title":"Bone and brain metastasis in lung cancer: recent advances in therapeutic strategies","volume":"6","author":"D'Antonio","year":"2014","journal-title":"Ther. Adv. Med Oncol."},{"issue":"8","key":"10.1016\/j.biopha.2025.118013_bib4","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1200\/JCO.2007.14.4147","article-title":"Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer","volume":"26","author":"Liedtke","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118013_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/bjc.2017.379","article-title":"Long-term survival outcomes of triple-receptor negative breast cancer survivors who are disease free at 5 years and relationship with low hormone receptor positivity","volume":"118","author":"Reddy","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2025.118013_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fonc.2018.00031","article-title":"Molecular mechanisms and emerging therapeutic targets of triple-negative breast cancer metastasis","volume":"8","author":"Neophytou","year":"2018","journal-title":"Front Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118013_bib7","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.18632\/oncotarget.12284","article-title":"Triple-negative breast cancer: is there a treatment on the horizon?","volume":"8","author":"Yao","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.biopha.2025.118013_bib8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/15384047.2017.1294288","article-title":"Anti-angiogenic treatment promotes triple-negative breast cancer invasion via vasculogenic mimicry","volume":"18","author":"Sun","year":"2017","journal-title":"Cancer Biol. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2025.118013_bib9","first-page":"1678","article-title":"Epithelial cell adhesion molecule and epithelial-mesenchymal transition are associated with vasculogenic mimicry, poor prognosis, and metastasis of triple negative breast cancer","volume":"12","author":"Wu","year":"2019","journal-title":"Int J. Clin. Exp. Pathol."},{"issue":"8","key":"10.1016\/j.biopha.2025.118013_bib10","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3390\/biom13081207","article-title":"Challenges and opportunities in developing targeted therapies for triple negative breast cancer","volume":"13","author":"Chapdelaine","year":"2023","journal-title":"Biomolecules"},{"issue":"34","key":"10.1016\/j.biopha.2025.118013_bib11","doi-asserted-by":"crossref","first-page":"56408","DOI":"10.18632\/oncotarget.16919","article-title":"Tumor vasculogenic mimicry formation as an unfavorable prognostic indicator in patients with breast cancer","volume":"8","author":"Shen","year":"2017","journal-title":"Oncotarget"},{"issue":"18","key":"10.1016\/j.biopha.2025.118013_bib12","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1016\/j.ejca.2013.07.148","article-title":"Tumour vasculogenic mimicry is associated with poor prognosis of human cancer patients: a systemic review and meta-analysis","volume":"49","author":"Cao","year":"2013","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2025.118013_bib13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10456-023-09876-7","article-title":"Pathological angiogenesis: mechanisms and therapeutic strategies","volume":"26","author":"Dudley","year":"2023","journal-title":"Angiogenesis"},{"key":"10.1016\/j.biopha.2025.118013_bib14","article-title":"Mechanisms of angiogenesis in tumour","volume":"14","author":"Zhang","year":"2024","journal-title":"Front Oncol."},{"key":"10.1016\/j.biopha.2025.118013_bib15","article-title":"Tumor angiogenesis: Current challenges and therapeutic opportunities","volume":"28","author":"Al-Ostoot","year":"2021","journal-title":"Cancer Treat. Res Commun."},{"key":"10.1016\/j.biopha.2025.118013_bib16","series-title":"Handbook of Cancer and Immunology","first-page":"1","article-title":"Angiogenesis and the tumor microenvironment","author":"Murphy","year":"2022"},{"issue":"4","key":"10.1016\/j.biopha.2025.118013_bib17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/ijc.30067","article-title":"Tumour angiogenesis-Origin of blood vessels","volume":"139","author":"Krishna Priya","year":"2016","journal-title":"Int J. Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2025.118013_bib18","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","article-title":"Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis","volume":"86","author":"Hanahan","year":"1996","journal-title":"Cell"},{"issue":"31","key":"10.1016\/j.biopha.2025.118013_bib19","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1038\/sj.onc.1209456","article-title":"Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma","volume":"25","author":"Ribatti","year":"2006","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.biopha.2025.118013_bib20","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/01.RES.80.6.845","article-title":"Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF","volume":"80","author":"Ziche","year":"1997","journal-title":"Circ. Res"},{"issue":"5","key":"10.1016\/j.biopha.2025.118013_bib21","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1172\/JCI117557","article-title":"Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P","volume":"94","author":"Ziche","year":"1994","journal-title":"J. Clin. Invest"},{"issue":"5","key":"10.1016\/j.biopha.2025.118013_bib22","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1161\/01.ATV.19.5.1156","article-title":"Role of endothelial nitric oxide synthase in endothelial cell migration","volume":"Vas 19","author":"Murohara","year":"1999","journal-title":"Arter. Throm"},{"key":"10.1016\/j.biopha.2025.118013_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.mvr.2018.04.001","article-title":"Nitric oxide signaling regulates tumor-induced intussusceptive-like angiogenesis","volume":"119","author":"Vimalraj","year":"2018","journal-title":"Micro Res"},{"issue":"12","key":"10.1016\/j.biopha.2025.118013_bib24","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/3957","article-title":"p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells","volume":"4","author":"Ambs","year":"1998","journal-title":"Nat. Med"},{"issue":"10","key":"10.1016\/j.biopha.2025.118013_bib25","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1021\/tx300274a","article-title":"Nitric Oxide Produced Endogenously Is Responsible for Hypoxia-Induced HIF-1\u03b1 Stabilization in Colon Carcinoma Cells","volume":"25","author":"Chowdhury","year":"2012","journal-title":"Chem. Res Toxicol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118013_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.repbio.2020.100474","article-title":"Downregulating miR-96-5p promotes proliferation, migration, and invasion, and inhibits apoptosis in human trophoblast cells via targeting DDAH1","volume":"21","author":"Chen","year":"2021","journal-title":"Reprod. Biol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118013_bib27","article-title":"Targeting cancer stem cells by melatonin: Effective therapy for cancer treatment","volume":"216","author":"Maroufi","year":"2020","journal-title":"Pathol. Res Pr."},{"issue":"5","key":"10.1016\/j.biopha.2025.118013_bib28","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.tranon.2016.07.002","article-title":"Angiogenesis and Antiangiogenesis in Triple-Negative Breast cancer","volume":"9","author":"Ribatti","year":"2016","journal-title":"Transl. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118013_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13045-020-00858-6","article-title":"Vasculogenic mimicry in carcinogenesis and clinical applications","volume":"13","author":"Luo","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118013_bib30","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0002-9440(10)65173-5","article-title":"Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry","volume":"155","author":"Maniotis","year":"1999","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118013_bib31","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.2353\/ajpath.2006.060223","article-title":"Tumor cell plasticity in uveal melanoma: microenvironment directed dampening of the invasive and metastatic genotype and phenotype accompanies the generation of vasculogenic mimicry patterns","volume":"169","author":"Folberg","year":"2006","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118013_bib32","doi-asserted-by":"crossref","DOI":"10.1186\/bcr1626","article-title":"A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cells","volume":"8","author":"Basu","year":"2006","journal-title":"Breast Cancer Res"},{"issue":"3","key":"10.1016\/j.biopha.2025.118013_bib33","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2174\/156720211796558023","article-title":"CD133+\u2009glioblastoma stem-like cells induce vascular mimicry in vivo","volume":"8","author":"Chiao","year":"2011","journal-title":"Curr. Neurovasc Res"},{"key":"10.1016\/j.biopha.2025.118013_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107805","article-title":"Vasculogenic mimicry, a complex and devious process favoring tumorigenesis-Interest in making it a therapeutic target","volume":"223","author":"Treps","year":"2021","journal-title":"Pharm. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2025.118013_bib35","first-page":"560","article-title":"Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft","volume":"62","author":"Shirakawa","year":"2002","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.biopha.2025.118013_bib36","doi-asserted-by":"crossref","first-page":"232","DOI":"10.30699\/IJP.2019.94997.1939","article-title":"Vascular Mimicry Expression in Invasive Ductal Carcinoma; A New Technique for Prospect of Aggressiveness","volume":"14","author":"Jafarian","year":"2019","journal-title":"Iran. J. Pathol."},{"key":"10.1016\/j.biopha.2025.118013_bib37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/B978-0-443-13342-8.00013-2","article-title":"Targeting dimethylarginine dimethylaminohydrolase 1 to suppress vasculogenic mimicry in breast cancer: Current evidence and future directions","author":"Mangoni","year":"2023","journal-title":"Nitric Oxide Health Dis."},{"issue":"5-6","key":"10.1016\/j.biopha.2025.118013_bib38","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/sj.bjc.6690125","article-title":"Blood flow influences vascular growth during tumour angiogenesis","volume":"79","author":"Nasu","year":"1999","journal-title":"Br. J. Cancer"},{"issue":"7-8","key":"10.1016\/j.biopha.2025.118013_bib39","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1600-0463.2004.apm11207-0810.x","article-title":"Vasculogenic mimicry","volume":"112","author":"Folberg","year":"2004","journal-title":"APMIS"},{"key":"10.1016\/j.biopha.2025.118013_bib40","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3389\/fonc.2019.00998","article-title":"Mechanisms of Vasculogenic Mimicry in Ovarian Cancer","volume":"9","author":"Ayala-Dominguez","year":"2019","journal-title":"Front Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118013_bib41","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1038\/s41467-018-07308-5","article-title":"Vasculogenic mimicry formation in EBV-associated epithelial malignancies","volume":"9","author":"Xiang","year":"2018","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.biopha.2025.118013_bib42","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1038\/s41388-018-0525-4","article-title":"IGFBP2 promotes vasculogenic mimicry formation via regulating CD144 and MMP2 expression in glioma","volume":"38","author":"Liu","year":"2019","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.biopha.2025.118013_bib43","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.3390\/jcm11051250","article-title":"The Role of Extracellular Matrix Proteins in Breast Cancer","volume":"11","author":"Lepucki","year":"2022","journal-title":"J. Clin. Med"},{"issue":"9","key":"10.1016\/j.biopha.2025.118013_bib44","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3390\/cells8090957","article-title":"Mechanisms of chemotherapy resistance in triple-negative breast cancer\u2014how we can rise to the challenge","volume":"8","author":"Nedeljkovi\u0107","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2025.118013_bib45","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2147\/IJWH.S406327","article-title":"Molecular Mechanisms Behind Vascular Mimicry as the Target for Improved Breast Cancer Management","volume":"15","author":"Wei","year":"2023","journal-title":"Int J. Women\u2019s. Health"},{"issue":"6","key":"10.1016\/j.biopha.2025.118013_bib46","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.21873\/anticanres.17045","article-title":"Ex vivo evaluation of antiangiogenic drugs in oral cancer: potential implications for targeting vasculogenic mimicry","volume":"44","author":"Hujanen","year":"2024","journal-title":"Anticancer Res"},{"issue":"8","key":"10.1016\/j.biopha.2025.118013_bib47","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.3390\/cancers13081912","article-title":"Alternative vascularization mechanisms in tumor resistance to therapy","volume":"13","author":"Belotti","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.biopha.2025.118013_bib48","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/iub.2233","article-title":"Targeting vasculogenic mimicry by phytochemicals: A potential opportunity for cancer therapy","volume":"72","author":"Haiaty","year":"2020","journal-title":"IUBMB Life"},{"issue":"2","key":"10.1016\/j.biopha.2025.118013_bib49","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s12282-021-01310-4","article-title":"Effect of Apatinib plus melatonin on vasculogenic mimicry formation by cancer stem cells from breast cancer cell line","volume":"29","author":"Maroufi","year":"2022","journal-title":"Breast Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2025.118013_bib50","first-page":"15","article-title":"Tumor Microenvironment","volume":"56","author":"Arneth","year":"2019","journal-title":"Med. (Kaunas. )"},{"issue":"23","key":"10.1016\/j.biopha.2025.118013_bib51","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1242\/jcs.116392","article-title":"The tumor microenvironment at a glance","volume":"125","author":"Balkwill","year":"2012","journal-title":"J. Cell Sci."},{"issue":"3","key":"10.1016\/j.biopha.2025.118013_bib52","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the crime: functions of cells recruited to the tumor microenvironment","volume":"21","author":"Hanahan","year":"2012","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.biopha.2025.118013_bib53","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3390\/cancers16061173","article-title":"A retrospective view of the triple-negative breast cancer microenvironment: novel markers, interactions, and mechanisms of tumor-associated components using public single-cell RNA-Seq datasets","volume":"16","author":"Kim","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.biopha.2025.118013_bib54","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/leu.2016.232","article-title":"Microenvironmental interactions between endothelial and lymphoma cells: a role for the canonical WNT pathway in Hodgkin lymphoma","volume":"31","author":"Linke","year":"2017","journal-title":"Leukemia"},{"issue":"18","key":"10.1016\/j.biopha.2025.118013_bib55","doi-asserted-by":"crossref","first-page":"13770","DOI":"10.3390\/ijms241813770","article-title":"The Inhibition of the FGFR\/PI3K\/Akt Axis by AZD4547 Disrupts the Proangiogenic Microenvironment and Vasculogenic Mimicry Arising from the Interplay between Endothelial and Triple-Negative Breast Cancer Cells","volume":"24","author":"Morales-Guadarrama","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118013_bib56","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3389\/fonc.2019.01419","article-title":"Regulation networks driving vasculogenic mimicry in solid tumors","volume":"9","author":"Hernandez de la Cruz","year":"2019","journal-title":"Front Oncol."},{"issue":"3-4","key":"10.1016\/j.biopha.2025.118013_bib57","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000430499","article-title":"Role of the tumor microenvironment in breast cancer","volume":"82","author":"Soysal","year":"2015","journal-title":"Pathobiology"},{"issue":"5","key":"10.1016\/j.biopha.2025.118013_bib58","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1002\/tox.24165","article-title":"Vasculogenic mimicry regulates immune infiltration and mutational status of the tumor microenvironment in breast cancer to influence tumor prognosis","volume":"39","author":"Zheng","year":"2024","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.biopha.2025.118013_bib59","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2018-000357","article-title":"How shall we treat early triple-negative breast cancer (TNBC): from the current standard to upcoming immuno-molecular strategies","volume":"3","author":"Park","year":"2018","journal-title":"Esmo Open"},{"issue":"10","key":"10.1016\/j.biopha.2025.118013_bib60","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1001\/jamaoncol.2016.1061","article-title":"Variation in the incidence and magnitude of tumor-infiltrating lymphocytes in breast cancer subtypes: a systematic review","volume":"2","author":"Stanton","year":"2016","journal-title":"JAMA Oncol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118013_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152500","article-title":"The prognostic value of tumor-infiltrating lymphocytes in breast cancer: a systematic review and meta-analysis","volume":"11","author":"Mao","year":"2016","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.biopha.2025.118013_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14102525","article-title":"Tumor-Infiltrating Lymphocytes (TILs) in Early Breast Cancer Patients: High CD3(+), CD8(+), and immunoscore are associated with a pathological complete response","volume":"14","author":"Rapoport","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.biopha.2025.118013_bib63","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/1097-0142(194907)2:4<635::AID-CNCR2820020411>3.0.CO;2-Q","article-title":"The relatively favorable prognosis of medullary carcinoma of the breast","volume":"2","author":"Moore","year":"1949","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.biopha.2025.118013_bib64","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1586\/era.12.147","article-title":"Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade","volume":"12","author":"Emens","year":"2012","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"2","key":"10.1016\/j.biopha.2025.118013_bib65","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s10549-011-1647-3","article-title":"CD8(+) cytotoxic T cell and FOXP3(+) regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes","volume":"130","author":"Liu","year":"2011","journal-title":"Breast Cancer Res Treat."},{"issue":"2","key":"10.1016\/j.biopha.2025.118013_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr3148","article-title":"CD8 lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer","volume":"14","author":"Liu","year":"2012","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.biopha.2025.118013_bib67","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.omtn.2017.06.009","article-title":"Regulatory Role of the MicroRNA-29b-IL-6 signaling in the formation of vascular mimicry","volume":"8","author":"Fang","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.biopha.2025.118013_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.618839","article-title":"IL-1\u03b2 Promotes Vasculogenic Mimicry of Breast Cancer Cells Through p38\/MAPK and PI3K\/Akt Signaling Pathways","volume":"11","author":"Nisar","year":"2021","journal-title":"Front Oncol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118013_bib69","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.3390\/ijms25073950","article-title":"Tumor Cell-Associated IL-1\u03b1 Affects Breast Cancer Progression and Metastasis in Mice through Manipulation of the Tumor Immune Microenvironment","volume":"25","author":"Krishnamohan","year":"2024","journal-title":"Int J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2025.118013_bib70","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1177\/1535370216685435","article-title":"Downregulation of transgelin blocks interleukin-8 utilization and suppresses vasculogenic mimicry in breast cancer cells","volume":"242","author":"Aikins","year":"2017","journal-title":"Exp. Biol. Med (Maywood)"},{"issue":"9","key":"10.1016\/j.biopha.2025.118013_bib71","article-title":"The role of tumor-associated macrophages in the development, metastasis and treatment of breast cancer","volume":"216","author":"Lu","year":"2020","journal-title":"Pathol. Res Pr."},{"issue":"1","key":"10.1016\/j.biopha.2025.118013_bib72","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12964-022-00888-2","article-title":"Tumor-associated macrophages promote epithelial-mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2\/AKT\/\u03b2-catenin signaling","volume":"20","author":"Chen","year":"2022","journal-title":"Cell Commun. Signal"},{"issue":"1","key":"10.1016\/j.biopha.2025.118013_bib73","first-page":"11","article-title":"Tumor-associated macrophages: effectors of angiogenesis and tumor progression","volume":"1796","author":"Coffelt","year":"2009","journal-title":"Biochim Biophys. Acta"},{"issue":"5","key":"10.1016\/j.biopha.2025.118013_bib74","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.3892\/mmr.2012.1043","article-title":"The effect of vascular endothelial growth factor C expression in tumor-associated macrophages on lymphangiogenesis and lymphatic metastasis in breast cancer","volume":"6","author":"Ding","year":"2012","journal-title":"Mol. Med Rep."},{"issue":"2","key":"10.1016\/j.biopha.2025.118013_bib75","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/jclinpath-2011-200355","article-title":"Tumour-infiltrating macrophages and clinical outcome in breast cancer","volume":"65","author":"Mahmoud","year":"2012","journal-title":"J. Clin. Pathol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118013_bib76","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10585-013-9627-0","article-title":"Modulation of matrix metalloproteinase-9 secretion from tumor-associated macrophage-like cells by proteolytically processed laminin-332 (laminin-5)","volume":"31","author":"Kamoshida","year":"2014","journal-title":"Clin. Exp. Metastas-.-."},{"issue":"1","key":"10.1016\/j.biopha.2025.118013_bib77","doi-asserted-by":"crossref","first-page":"9188","DOI":"10.1038\/srep09188","article-title":"Characterization of macrophage--cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer","volume":"5","author":"Hollmen","year":"2015","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2025.118013_bib78","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbcan.2017.10.007","article-title":"Triple negative breast cancer: Key role of Tumor-Associated Macrophages in regulating the activity of anti-PD-1\/PD-L1 agents","volume":"1869","author":"Santoni","year":"2018","journal-title":"Biochim Biophys. Acta Rev. Cancer"},{"issue":"12","key":"10.1016\/j.biopha.2025.118013_bib79","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1007\/s12094-021-02652-3","article-title":"Tumor microenvironment in triple-negative breast cancer: the correlation of tumor-associated macrophages and tumor-infiltrating lymphocytes","volume":"23","author":"Kuroda","year":"2021","journal-title":"Clin. Transl. Oncol."},{"issue":"49","key":"10.1016\/j.biopha.2025.118013_bib80","doi-asserted-by":"crossref","first-page":"13030","DOI":"10.1073\/pnas.1709119114","article-title":"Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer","volume":"114","author":"Basudhar","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biopha.2025.118013_bib81","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1038\/s41467-021-24703-7","article-title":"TEM8 marks neovasculogenic tumor-initiating cells in triple-negative breast cancer","volume":"12","author":"Xu","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2025.118013_bib82","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1038\/s41467-022-31764-9","article-title":"Hypoxia induces HIF1alpha-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapy","volume":"13","author":"Ma","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2025.118013_bib83","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1186\/s12967-023-04575-9","article-title":"Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies","volume":"21","author":"Li","year":"2023","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.biopha.2025.118013_bib84","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fonc.2020.00220","article-title":"An overview of vasculogenic mimicry in breast cancer","volume":"10","author":"Andonegui-Elguera","year":"2020","journal-title":"Front Oncol."},{"key":"10.1016\/j.biopha.2025.118013_bib85","series-title":"Nitric Oxide in Health and Disease","first-page":"135","article-title":"Cancer stem cells and nitric oxide","author":"Taskiran","year":"2023"},{"issue":"2","key":"10.1016\/j.biopha.2025.118013_bib86","doi-asserted-by":"crossref","first-page":"299","DOI":"10.20892\/j.issn.2095-3941.2018.0209","article-title":"Cancer stem-like cells directly participate in vasculogenic mimicry channels in triple-negative breast cancer","volume":"16","author":"Sun","year":"2019","journal-title":"Cancer Biol. Med"},{"issue":"5","key":"10.1016\/j.biopha.2025.118013_bib87","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3390\/cells10051070","article-title":"Cancer stem cells and neovascularization","volume":"10","author":"Li","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.biopha.2025.118013_bib88","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/bph.14488","article-title":"Understanding the tumour micro-environment communication network from an NOS2\/COX2 perspective","volume":"176","author":"Basudhar","year":"2019","journal-title":"Br. J. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2025.118013_bib89","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/2320206820960862","article-title":"A review on cancer stem cells in vasculogenic mimicry formation: a new dimension for targeted therapy","volume":"12","author":"Murugesan","year":"2021","journal-title":"J. Adv. Oral. Res"},{"issue":"6","key":"10.1016\/j.biopha.2025.118013_bib90","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1267\/ahc.18041","article-title":"Stem-like human breast cancer cells initiate vasculogenic mimicry on matrigel","volume":"51","author":"Izawa","year":"2018","journal-title":"Acta Histochem Cytochem"},{"issue":"1","key":"10.1016\/j.biopha.2025.118013_bib91","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1530\/ERC-19-0054","article-title":"Stem-like tumor cells involved in heterogeneous vasculogenesis in breast cancer","volume":"27","author":"Mao","year":"2020","journal-title":"Endocr. Relat. Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2025.118013_bib92","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/onc.2012.85","article-title":"CD133+\u2009cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer","volume":"32","author":"Liu","year":"2013","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.biopha.2025.118013_bib93","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1159\/000493227","article-title":"ALDH1 Expression and Vasculogenic Mimicry Are Positively Associated with Poor Prognosis in Patients with Breast Cancer","volume":"49","author":"Xing","year":"2018","journal-title":"Cell Physiol. Biochem"},{"issue":"7","key":"10.1016\/j.biopha.2025.118013_bib94","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.3390\/cells10071758","article-title":"Vasculogenic mimicry in breast cancer: clinical relevance and drivers","volume":"10","author":"Morales-Guadarrama","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2025.118013_bib95","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7512632","article-title":"CD133 in breast cancer cells: more than a stem cell marker","volume":"2019","author":"Brugnoli","year":"2019","journal-title":"J. Oncol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118013_bib96","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Al-Hajj","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.biopha.2025.118013_bib97","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/jcp.2011.090456","article-title":"Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype","volume":"64","author":"Ricardo","year":"2011","journal-title":"J. Clin. Pathol."},{"issue":"18","key":"10.1016\/j.biopha.2025.118013_bib98","doi-asserted-by":"crossref","first-page":"30502","DOI":"10.18632\/oncotarget.8461","article-title":"Epithelial-to-endothelial transition and cancer stem cells: two cornerstones of vasculogenic mimicry in malignant tumors","volume":"8","author":"Sun","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.biopha.2025.118013_bib99","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/hep.23311","article-title":"Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry","volume":"51","author":"Sun","year":"2010","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.biopha.2025.118013_bib100","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/jcmm.12851","article-title":"The relationship between vasculogenic mimicry and epithelial-mesenchymal transitions","volume":"20","author":"Liu","year":"2016","journal-title":"J. Cell Mol. Med"},{"issue":"3","key":"10.1016\/j.biopha.2025.118013_bib101","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.yexmp.2015.03.030","article-title":"ZEB2 promotes vasculogenic mimicry by TGF-beta1 induced epithelial-to-mesenchymal transition in hepatocellular carcinoma","volume":"98","author":"Yang","year":"2015","journal-title":"Exp. Mol. Pathol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118013_bib102","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1615\/CritRevEukaryotGeneExpr.2015014042","article-title":"Epithelial mesenchymal transition and vascular mimicry in breast cancer stem cells","volume":"25","author":"Kotiyal","year":"2015","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"issue":"6","key":"10.1016\/j.biopha.2025.118013_bib103","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1177\/1533034617742312","article-title":"Phosphorylation of STAT3 promotes vasculogenic mimicry by inducing epithelial-to-mesenchymal transition in colorectal cancer","volume":"16","author":"Han","year":"2017","journal-title":"Technol. Cancer Res Treat."},{"issue":"10","key":"10.1016\/j.biopha.2025.118013_bib104","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3390\/cancers9100134","article-title":"The epithelial-to-mesenchymal transition in breast cancer: focus on basal-like carcinomas","volume":"9","author":"Fedele","year":"2017","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biopha.2025.118013_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173282","article-title":"Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells","volume":"881","author":"Maroufi","year":"2020","journal-title":"Eur. J. Pharm."},{"issue":"13","key":"10.1016\/j.biopha.2025.118013_bib106","doi-asserted-by":"crossref","first-page":"7163","DOI":"10.1111\/jcmm.15167","article-title":"Twist1 accelerates tumour vasculogenic mimicry by inhibiting Claudin15 expression in triple-negative breast cancer","volume":"24","author":"Zhang","year":"2020","journal-title":"J. Cell Mol. Med"},{"issue":"13","key":"10.1016\/j.biopha.2025.118013_bib107","doi-asserted-by":"crossref","first-page":"11087","DOI":"10.18632\/oncotarget.3571","article-title":"Claudin-4 is required for vasculogenic mimicry formation in human breast cancer cells","volume":"6","author":"Cui","year":"2015","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.biopha.2025.118013_bib108","first-page":"6711","article-title":"Knockdown of ZEB1 suppressed the formation of vasculogenic mimicry and epithelial-mesenchymal transition in the human breast cancer cell line MDA-MB-231","volume":"17","author":"Liang","year":"2018","journal-title":"Mol. Med Rep."},{"issue":"1","key":"10.1016\/j.biopha.2025.118013_bib109","article-title":"Role of ICAM-1 in triple-negative breast cancer","volume":"19","author":"Zhang","year":"2024","journal-title":"Open Med (Wars. )"},{"issue":"12","key":"10.1016\/j.biopha.2025.118013_bib110","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrclinonc.2017.101","article-title":"The immune contexture in cancer prognosis and treatment","volume":"14","author":"Fridman","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biopha.2025.118013_bib111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CMAR.S316700","article-title":"The Characteristics of Tumor Microenvironment in Triple Negative Breast Cancer","volume":"14","author":"Fan","year":"2022","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.biopha.2025.118013_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115015","article-title":"Evaluation of the association of chronic inflammation and cancer: Insights and implications","volume":"164","author":"Nigam","year":"2023","journal-title":"Biomed. Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2025.118013_bib113","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.semcancer.2004.06.006","article-title":"Inflammation as a tumor promoter in cancer induction","volume":"14","author":"Philip","year":"2004","journal-title":"Semin Cancer Biol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118013_bib114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr1746","article-title":"Inflammation and breast cancer - Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression","volume":"9","author":"DeNardo","year":"2007","journal-title":"Breast Cancer Res"},{"issue":"2","key":"10.1016\/j.biopha.2025.118013_bib115","first-page":"3356","article-title":"Role of the IL-8\/CXCR2 axis in promoting vasculogenic mimicry in triple-negative breast cancer through epithelial-mesenchymal transition","volume":"6","author":"Abdulkarim","year":"2024","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2025.118013_bib116","doi-asserted-by":"crossref","first-page":"R422","DOI":"10.1186\/bcr1019","article-title":"Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells","volume":"7","author":"Basu","year":"2005","journal-title":"Breast Cancer Res"},{"issue":"9","key":"10.1016\/j.biopha.2025.118013_bib117","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1002\/stem.2426","article-title":"COX-2 Induces Breast Cancer Stem Cells via EP4\/PI3K\/AKT\/NOTCH\/WNT Axis","volume":"34","author":"Majumder","year":"2016","journal-title":"Stem Cells"},{"issue":"4","key":"10.1016\/j.biopha.2025.118013_bib118","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s10555-022-10067-x","article-title":"Physicochemical aspects of the tumour microenvironment as drivers of vasculogenic mimicry","volume":"41","author":"Andreucci","year":"2022","journal-title":"Cancer Metast Rev."},{"issue":"1","key":"10.1016\/j.biopha.2025.118013_bib119","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12943-020-01288-1","article-title":"Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments","volume":"20","author":"Wei","year":"2021","journal-title":"Mol. Cancer"},{"issue":"7494","key":"10.1016\/j.biopha.2025.118013_bib120","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature13119","article-title":"XBP1 promotes triple-negative breast cancer by controlling the HIF1alpha pathway","volume":"508","author":"Chen","year":"2014","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.biopha.2025.118013_bib121","doi-asserted-by":"crossref","first-page":"14851","DOI":"10.1007\/s13277-016-5331-4","article-title":"Transcription factor HIF1A: downstream targets, associated pathways, polymorphic hypoxia response element (HRE) sites, and initiative for standardization of reporting in scientific literature","volume":"37","author":"Slemc","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.biopha.2025.118013_bib122","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/1476-4598-13-207","article-title":"Twist1 expression induced by sunitinib accelerates tumor cell vasculogenic mimicry by increasing the population of CD133+\u2009cells in triple-negative breast cancer","volume":"13","author":"Zhang","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2025.118013_bib123","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.biopha.2017.11.137","article-title":"Inhibitory effects of compound DMBT on hypoxia-induced vasculogenic mimicry in human breast cancer","volume":"96","author":"Li","year":"2017","journal-title":"Biomed. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2025.118013_bib124","article-title":"Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2\/focal adhesion kinase\/paxillin signaling pathway","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.biopha.2025.118013_bib125","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1111\/jcmm.13625","article-title":"TP53INP1 inhibits hypoxia-induced vasculogenic mimicry formation via the ROS\/snail signalling axis in breast cancer","volume":"22","author":"Wang","year":"2018","journal-title":"J. Cell Mol. Med"},{"issue":"2","key":"10.1016\/j.biopha.2025.118013_bib126","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","article-title":"Oxidative Stress in Cancer","volume":"38","author":"Hayes","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2025.118013_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103285","article-title":"Reactive oxygen species (ROS): Critical roles in breast tumor microenvironment","volume":"160","author":"Malla","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.biopha.2025.118013_bib128","doi-asserted-by":"crossref","DOI":"10.1177\/1177271918755391","article-title":"Reactive Oxygen Species: A Key Constituent in Cancer Survival","volume":"13","author":"Kumari","year":"2018","journal-title":"Biomark. Insights"},{"issue":"11","key":"10.1016\/j.biopha.2025.118013_bib129","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.freeradbiomed.2010.09.006","article-title":"Oxidative stress, inflammation, and cancer: how are they linked?","volume":"49","author":"Reuter","year":"2010","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.biopha.2025.118013_bib130","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3389\/fonc.2019.00480","article-title":"Breast cancer subtypes present a differential production of reactive oxygen species (ROS) and susceptibility to antioxidant treatment","volume":"9","author":"Sarmiento-Salinas","year":"2019","journal-title":"Front Oncol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118013_bib131","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.freeradbiomed.2011.05.042","article-title":"HIF-1alpha stabilization by mitochondrial ROS promotes Met-dependent invasive growth and vasculogenic mimicry in melanoma cells","volume":"51","author":"Comito","year":"2011","journal-title":"Free Radic. Biol. Med"},{"issue":"22","key":"10.1016\/j.biopha.2025.118013_bib132","doi-asserted-by":"crossref","first-page":"10823","DOI":"10.1158\/0008-5472.CAN-07-0783","article-title":"Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor","volume":"67","author":"Xia","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2025.118013_bib133","series-title":"Cancer","first-page":"3","article-title":"The role of oxidative stress in breast cancer","author":"Devi","year":"2014"},{"issue":"11","key":"10.1016\/j.biopha.2025.118013_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103761","article-title":"Leveraging hypoxia in triple-negative breast cancer as a promising treatment strategy","volume":"28","author":"Bhise","year":"2023","journal-title":"Drug Discov. Today"},{"issue":"2","key":"10.1016\/j.biopha.2025.118013_bib135","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.3390\/ijms13021347","article-title":"MetastamiRs: non-coding MicroRNAs driving cancer invasion and metastasis","volume":"13","author":"Lopez-Camarillo","year":"2012","journal-title":"Int J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.biopha.2025.118013_bib136","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1101\/gad.1953310","article-title":"Canonical and alternate functions of the microRNA biogenesis machinery","volume":"24","author":"Chong","year":"2010","journal-title":"Genes Dev."},{"issue":"1","key":"10.1016\/j.biopha.2025.118013_bib137","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/genes12010009","article-title":"MicroRNA 34a-AXL Axis Regulates Vasculogenic Mimicry Formation in Breast Cancer Cells","volume":"12","author":"Lim","year":"2020","journal-title":"Genes (Basel)"},{"issue":"8","key":"10.1016\/j.biopha.2025.118013_bib138","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1080\/1744666X.2024.2352484","article-title":"Functional roles of microRNAs in vasculogenic mimicry and resistance to therapy in human cancers: an update","volume":"20","author":"Garcia-Hernandez","year":"2024","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118013_bib139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/mmr.2020.11668","article-title":"Effects of miR\u201193 on epithelial\u2011to\u2011mesenchymal transition and vasculogenic mimicry in triple\u2011negative breast cancer cells","volume":"23","author":"An","year":"2021","journal-title":"Mol. Med Rep."},{"issue":"1","key":"10.1016\/j.biopha.2025.118013_bib140","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14454-1","article-title":"MiR-193b regulates breast cancer cell migration and vasculogenic mimicry by targeting dimethylarginine dimethylaminohydrolase 1","volume":"7","author":"Hulin","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2025.118013_bib141","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.bbrc.2018.08.122","article-title":"Knockdown of long non-coding RNA TP73-AS1 suppresses triple negative breast cancer cell vasculogenic mimicry by targeting miR-490-3p\/TWIST1 axis","volume":"504","author":"Tao","year":"2018","journal-title":"Biochem Biophys. Res Commun."},{"issue":"8","key":"10.1016\/j.biopha.2025.118013_bib142","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/onc.2017.356","article-title":"ZEB1-repressed microRNAs inhibit autocrine signaling that promotes vascular mimicry of breast cancer cells","volume":"37","author":"Langer","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2025.118013_bib143","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.canlet.2018.06.003","article-title":"Cooperative multi-targeting of signaling networks by angiomiR-204 inhibits vasculogenic mimicry in breast cancer cells","volume":"432","author":"Salinas-Vera","year":"2018","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.biopha.2025.118013_bib144","first-page":"19","article-title":"HOX Transcript Antisense RNA HOTAIR Abrogates Vasculogenic Mimicry by Targeting the AngiomiR-204\/FAK Axis in Triple Negative Breast Cancer Cells","volume":"6","author":"Lozano-Romero","year":"2020","journal-title":"Noncoding RNA"},{"issue":"1","key":"10.1016\/j.biopha.2025.118013_bib145","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1186\/s12885-024-13019-6","article-title":"The lncRNA AFAP1-AS1 is upregulated in metastatic triple-negative breast tumors and controls hypoxia-activated vasculogenic mimicry and angiogenesis","volume":"24","author":"Garcia-Hernandez","year":"2024","journal-title":"BMC Cancer"},{"issue":"18","key":"10.1016\/j.biopha.2025.118013_bib146","doi-asserted-by":"crossref","first-page":"6369","DOI":"10.1073\/pnas.84.18.6369","article-title":"Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: precursors and role of the respiratory burst","volume":"84","author":"Iyengar","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2025.118013_bib147","doi-asserted-by":"crossref","unstructured":"D.J. Stuehr, N.S. Kwon, C.F. Nathan, O.W. Griffith, P. Feldman, J. WisemanN omega-hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine, Journal of Biological Chemistry 266 (10) (1991) 6259-6263.","DOI":"10.1016\/S0021-9258(18)38112-2"},{"issue":"5-6","key":"10.1016\/j.biopha.2025.118013_bib148","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.cr.7290133","article-title":"The role of nitric oxide in cancer","volume":"12","author":"Xu","year":"2002","journal-title":"Cell Res"},{"issue":"3","key":"10.1016\/j.biopha.2025.118013_bib149","doi-asserted-by":"crossref","first-page":"C780","DOI":"10.1152\/ajpcell.00153.2023","article-title":"Inducible nitric oxide synthase activity mediates TNF-alpha-induced endothelial cell dysfunction","volume":"325","author":"Liu","year":"2023","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"18","key":"10.1016\/j.biopha.2025.118013_bib150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184592","article-title":"The Second Life of Methylarginines as Cardiovascular Targets","volume":"20","author":"Jarzebska","year":"2019","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118013_bib151","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.molcel.2016.11.003","article-title":"Arginine Methylation: The Coming of Age","volume":"65","author":"Blanc","year":"2017","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.biopha.2025.118013_bib152","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1021\/acschembio.5b00839","article-title":"A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases","volume":"11","author":"Eram","year":"2016","journal-title":"ACS Chem. Biol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118013_bib153","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/cmdc.202100018","article-title":"Rational design and synthesis of selective PRMT4 inhibitors: a new chemotype for development of cancer therapeutics","volume":"16","author":"Sutherland","year":"2021","journal-title":"ChemMedChem"},{"issue":"9","key":"10.1016\/j.biopha.2025.118013_bib154","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/eurheartj\/ehp061","article-title":"Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis","volume":"30","author":"Antoniades","year":"2009","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.biopha.2025.118013_bib155","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1567-5688(03)00032-1","article-title":"The DDAH\/ADMA\/NOS pathway","volume":"4","author":"Tran","year":"2003","journal-title":"Atheroscler. Suppl."},{"issue":"1 (1_","key":"10.1016\/j.biopha.2025.118013_bib156","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1177\/1358836X0501000111","article-title":"ADMA metabolism and clearance","volume":"10","author":"Teerlink","year":"2005","journal-title":"Vasc. Med"},{"issue":"Pt 1 (Pt 1)","key":"10.1016\/j.biopha.2025.118013_bib157","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1042\/bj3430209","article-title":"Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases","volume":"343","author":"Leiper","year":"1999","journal-title":"Biochem J."},{"issue":"1","key":"10.1016\/j.biopha.2025.118013_bib158","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1038\/s41467-023-38467-9","article-title":"A multicentric consortium study demonstrates that dimethylarginine dimethylaminohydrolase 2 is not a dimethylarginine dimethylaminohydrolase","volume":"14","author":"Ragavan","year":"2023","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.biopha.2025.118013_bib159","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1124\/pharmrev.124.001060","article-title":"Nitric oxide signaling and regulation in the cardiovascular system: recent advances","volume":"76","author":"Carlstrom","year":"2024","journal-title":"Pharm. Rev."},{"issue":"16","key":"10.1016\/j.biopha.2025.118013_bib160","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1016\/j.cell.2022.06.010","article-title":"Nitric oxide signaling in health and disease","volume":"185","author":"Lundberg","year":"2022","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.biopha.2025.118013_bib161","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nrn2214","article-title":"Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity","volume":"8","author":"Calabrese","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.biopha.2025.118013_bib162","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.ATV.19.3.656","article-title":"Upregulation of superoxide dismutase and nitric oxide synthase mediates the apoptosis-suppressive effects of shear stress on endothelial cells","volume":"Vas 19","author":"Dimmeler","year":"1999","journal-title":"Arter. Throm"},{"issue":"9","key":"10.1016\/j.biopha.2025.118013_bib163","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1161\/01.CIR.99.9.1236","article-title":"Regression of atherosclerosis: role of nitric oxide and apoptosis","volume":"99","author":"Wang","year":"1999","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.biopha.2025.118013_bib164","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/01.RES.65.3.789","article-title":"N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor","volume":"65","author":"Stamler","year":"1989","journal-title":"Circ. Res"},{"issue":"11","key":"10.1016\/j.biopha.2025.118013_bib165","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1161\/01.RES.87.11.999","article-title":"Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide\/cGMP signaling and endothelial dysfunction","volume":"87","author":"Oelze","year":"2000","journal-title":"Circ. Res"},{"key":"10.1016\/j.biopha.2025.118013_bib166","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.niox.2021.03.002","article-title":"Prognostic value of asymmetric dimethylarginine in patients with coronary artery disease: a meta-analysis","volume":"109-110","author":"Ye","year":"2021","journal-title":"Nitric Oxide"},{"issue":"1","key":"10.1016\/j.biopha.2025.118013_bib167","doi-asserted-by":"crossref","first-page":"49","DOI":"10.18388\/abp.2003_3713","article-title":"Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis","volume":"50","author":"Kimura","year":"2003","journal-title":"Acta Biochim Pol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118013_bib168","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.3390\/ijms24065871","article-title":"Inhaled nitric oxide promotes angiogenesis in the rodent developing brain","volume":"24","author":"Loron","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2025.118013_bib169","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0006-291X(02)02029-6","article-title":"Effects of nitric oxide donors on vascular endothelial growth factor gene induction","volume":"296","author":"Kimura","year":"2002","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.biopha.2025.118013_bib170","first-page":"332","article-title":"Effects of asymmetric dimethylarginine on bovine retinal capillary endothelial cell proliferation, reactive oxygen species production, permeability, intercellular adhesion molecule-1, and occludin expression","volume":"17","author":"Chen","year":"2011","journal-title":"Mol. Vis."},{"issue":"1","key":"10.1016\/j.biopha.2025.118013_bib171","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijcard.2014.06.062","article-title":"Increased concentration of circulating angiogenesis and nitric oxide inhibitors induces endothelial to mesenchymal transition and myocardial fibrosis in patients with chronic kidney disease","volume":"176","author":"Charytan","year":"2014","journal-title":"Int J. Cardiol."},{"issue":"12","key":"10.1016\/j.biopha.2025.118013_bib172","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1161\/ATVBAHA.109.194035","article-title":"The ADMA\/DDAH pathway regulates VEGF-mediated angiogenesis","volume":"Vas 29","author":"Fiedler","year":"2009","journal-title":"Arter. Throm"},{"issue":"1","key":"10.1016\/j.biopha.2025.118013_bib173","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/physrev.00029.2006","article-title":"Nitric oxide and peroxynitrite in health and disease","volume":"87","author":"Pacher","year":"2007","journal-title":"Physiol. Rev."},{"issue":"21","key":"10.1016\/j.biopha.2025.118013_bib174","doi-asserted-by":"crossref","first-page":"15941","DOI":"10.1021\/acs.inorgchem.1c02434","article-title":"Nitric Oxide and Cancer: When to Give and When to Take Away?","volume":"60","author":"Miranda","year":"2021","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.biopha.2025.118013_bib175","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.niox.2019.09.005","article-title":"Nitric oxide and its derivatives in the cancer battlefield","volume":"93","author":"Kamm","year":"2019","journal-title":"Nitric Oxide"},{"issue":"8","key":"10.1016\/j.biopha.2025.118013_bib176","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1089\/ars.2018.7527","article-title":"Molecular mechanisms of nitric oxide in cancer progression, signal transduction, and metabolism","volume":"30","author":"Somasundaram","year":"2019","journal-title":"Antioxid. Redox Signal"},{"issue":"24","key":"10.1016\/j.biopha.2025.118013_bib177","doi-asserted-by":"crossref","first-page":"9393","DOI":"10.3390\/ijms21249393","article-title":"ThE Role of Nitric Oxide in Cancer: Master Regulator Or Not?","volume":"21","author":"Khan","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118013_bib178","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.biopha.2018.12.117","article-title":"Small molecule inhibition of DDAH1 significantly attenuates triple negative breast cancer cell vasculogenic mimicry","volume":"111","author":"Hulin","year":"2019","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2025.118013_bib179","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.3389\/fonc.2019.01455","article-title":"Inhibition of dimethylarginine dimethylaminohydrolase (DDAH) enzymes as an emerging therapeutic strategy to target angiogenesis and vasculogenic mimicry in cancer","volume":"9","author":"Hulin","year":"2020","journal-title":"Front Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118013_bib180","doi-asserted-by":"crossref","first-page":"C89","DOI":"10.1152\/ajpcell.00187.2014","article-title":"Nitric oxide induces cancer stem cell-like phenotypes in human lung cancer cells","volume":"308","author":"Yongsanguanchai","year":"2015","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.biopha.2025.118013_bib181","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/978-3-030-50224-9_10","article-title":"Tumor microenvironment and nitric oxide: concepts and mechanisms","volume":"1277","author":"Vedenko","year":"2020","journal-title":"Adv. Exp. Med Biol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118013_bib182","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.freeradbiomed.2008.03.020","article-title":"The chemical biology of nitric oxide: implications in cellular signaling","volume":"45","author":"Thomas","year":"2008","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.biopha.2025.118013_bib183","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113861","article-title":"Targeting hypoxia-inducible factor-1alpha: A new strategy for triple-negative breast cancer therapy","volume":"156","author":"Liu","year":"2022","journal-title":"Biomed. Pharm."},{"issue":"46","key":"10.1016\/j.biopha.2025.118013_bib184","doi-asserted-by":"crossref","first-page":"80568","DOI":"10.18632\/oncotarget.19631","article-title":"Impact of inducible nitric oxide synthase (iNOS) expression on triple negative breast cancer outcome and activation of EGFR and ERK signaling pathways","volume":"8","author":"Garrido","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2025.118013_bib185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.niox.2019.04.009","article-title":"Nitric oxide and interactions with reactive oxygen species in the development of melanoma, breast, and colon cancer: A redox signaling perspective","volume":"89","author":"Monteiro","year":"2019","journal-title":"Nitric Oxide"},{"issue":"7","key":"10.1016\/j.biopha.2025.118013_bib186","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130286","article-title":"Clinical Implications of iNOS Levels in Triple-Negative Breast Cancer Responding to Neoadjuvant Chemotherapy","volume":"10","author":"Jin","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biopha.2025.118013_bib187","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1172\/JCI65416","article-title":"TGF-beta inhibition enhances chemotherapy action against triple-negative breast cancer","volume":"123","author":"Bhola","year":"2013","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.biopha.2025.118013_bib188","article-title":"Vascular mimicry: a potential therapeutic target in breast cancer","volume":"234","author":"Chavoshi","year":"2022","journal-title":"Pathol. Res Pr."},{"issue":"4","key":"10.1016\/j.biopha.2025.118013_bib189","first-page":"321","article-title":"Novel multifunctional nanoliposomes inhibit alpha-synuclein fibrillization, attenuate microglial activation, and silence the expression of SNCA gene","volume":"39","author":"Jebali","year":"2024","journal-title":"Neurol. (Engl. Ed."},{"key":"10.1016\/j.biopha.2025.118013_bib190","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.918340","article-title":"Vitamin D exerts significant antitumor effects by Suppressing Vasculogenic Mimicry in Breast Cancer Cells","volume":"12","author":"Bajbouj","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.biopha.2025.118013_bib191","article-title":"Brucine Suppresses Vasculogenic Mimicry in Human Triple-Negative Breast Cancer Cell Line MDA-MB-231","volume":"2019","author":"Xu","year":"2019","journal-title":"Biomed. Res Int"},{"key":"10.1016\/j.biopha.2025.118013_bib192","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109202","article-title":"2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol (SQ) inhibits cancer cell metastasis behavior of TNBC via suppressing EMT and VEGF","volume":"329","author":"Zheng","year":"2020","journal-title":"Chem. -Biol. Inter."},{"issue":"3","key":"10.1016\/j.biopha.2025.118013_bib193","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1158\/2767-9764.CRC-23-0278","article-title":"Antibody-Drug Conjugate \u03b1EGFR-E-P125A Reduces Triple-negative Breast Cancer Vasculogenic Mimicry, Motility, and Metastasis through Inhibition of EGFR, Integrin, and FAK\/STAT3 Signaling","volume":"4","author":"Sankar","year":"2024","journal-title":"Cancer Res Commun."},{"issue":"14","key":"10.1016\/j.biopha.2025.118013_bib194","doi-asserted-by":"crossref","first-page":"7659","DOI":"10.3390\/ijms23147659","article-title":"Endothelium-Dependent Induction of Vasculogenic Mimicry in Human Triple-Negative Breast Cancer Cells Is Inhibited by Calcitriol and Curcumin","volume":"23","author":"Morales-Guadarrama","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"24","key":"10.1016\/j.biopha.2025.118013_bib195","doi-asserted-by":"crossref","first-page":"16171","DOI":"10.3390\/ijms232416171","article-title":"PARP Inhibitor Inhibits the Vasculogenic Mimicry through a NF-\u03baB-PTX3 Axis Signaling in Breast Cancer Cells","volume":"23","author":"Chivot","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118013_bib196","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13020-022-00597-5","article-title":"Investigating the mechanism of Xian-ling-lian-xia-fang for inhibiting vasculogenic mimicry in triple negative breast cancer via blocking VEGF\/MMPs pathway","volume":"17","author":"Li","year":"2022","journal-title":"Chin. Med"},{"issue":"3","key":"10.1016\/j.biopha.2025.118013_bib197","first-page":"438","article-title":"Agkistrodon halys venom antitumor component-I inhibits vasculogenic mimicry in triple-negative breast cancer cells in vitro by down-regulating MMP2]","volume":"42","author":"Ge","year":"2022","journal-title":"Nan Fang. Yi Ke Da Xue Xue Bao"},{"key":"10.1016\/j.biopha.2025.118013_bib198","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1186\/s12885-015-1784-x","article-title":"Molecular mechanism of anti-cancer activity of phycocyanin in triple-negative breast cancer cells","volume":"15","author":"Ravi","year":"2015","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2025.118013_bib199","doi-asserted-by":"crossref","first-page":"531","DOI":"10.7314\/APJCP.2015.16.2.531","article-title":"Effect of grape seed proanthocyanidins on tumor vasculogenic mimicry in human triple-negative breast cancer cells","volume":"16","author":"Luan","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"5","key":"10.1016\/j.biopha.2025.118013_bib200","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1158\/1078-0432.CCR-17-1437","article-title":"Pharmacological Inhibition of NOS Activates ASK1\/JNK Pathway Augmenting Docetaxel-Mediated Apoptosis in Triple-Negative Breast Cancer","volume":"24","author":"Davila-Gonzalez","year":"2018","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.biopha.2025.118013_bib201","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13058-015-0527-x","article-title":"Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer","volume":"17","author":"Granados-Principal","year":"2015","journal-title":"Breast Cancer Res"},{"issue":"1","key":"10.1016\/j.biopha.2025.118013_bib202","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10456-017-9587-0","article-title":"Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA)","volume":"21","author":"Reddy","year":"2018","journal-title":"Angiogenesis"},{"key":"10.1016\/j.biopha.2025.118013_bib203","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.niox.2023.06.002","article-title":"Nitric oxide synthase inhibitors as potential therapeutic agents for gliomas: A systematic review","author":"Merenzon","year":"2023","journal-title":"Nitric Oxide-Biol. Ch 138"},{"issue":"624","key":"10.1016\/j.biopha.2025.118013_bib204","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj5070","article-title":"A phase 1\/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer","volume":"13","author":"Chung","year":"2021","journal-title":"Sci. Transl. Med"},{"issue":"1","key":"10.1016\/j.biopha.2025.118013_bib205","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54651-x","article-title":"NOS inhibition sensitizes metaplastic breast cancer to PI3K inhibition and taxane therapy via c-JUN repression","volume":"15","author":"Reddy","year":"2024","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.biopha.2025.118013_bib206","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1093\/ndt\/gfad103","article-title":"I. the Chronic Renal Insufficiency Cohort Study, Association of urine and plasma ADMA with atherosclerotic risk in DKD cardiovascular disease risk in diabetic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) study","volume":"38","author":"Schrauben","year":"2023","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.biopha.2025.118013_bib207","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.niox.2018.06.004","article-title":"Asymmetric dimethylarginine (ADMA) as an important risk factor for the increased cardiovascular diseases and heart failure in chronic kidney disease","volume":"78","author":"Liu","year":"2018","journal-title":"Nitric Oxide-Biol. Ch"},{"issue":"9","key":"10.1016\/j.biopha.2025.118013_bib208","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/BF03401818","article-title":"Inhibition of neuronal nitric oxide synthase increases aggressive behavior in mice","volume":"3","author":"Demas","year":"1997","journal-title":"Mol. Med"},{"issue":"5","key":"10.1016\/j.biopha.2025.118013_bib209","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/cvr\/cvab155","article-title":"Neuronal nitric oxide synthase regulates regional brain perfusion in healthy humans","volume":"118","author":"O'Gallagher","year":"2022","journal-title":"Cardiovasc Res"},{"issue":"5","key":"10.1016\/j.biopha.2025.118013_bib210","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1177\/2047487315586094","article-title":"Levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, and risk of coronary artery disease: A meta-analysis based on 4713 participants","volume":"23","author":"Xuan","year":"2016","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118013_bib211","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/07853890500472151","article-title":"Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond","volume":"38","author":"Boger","year":"2006","journal-title":"Ann. Med"},{"issue":"46","key":"10.1016\/j.biopha.2025.118013_bib212","doi-asserted-by":"crossref","first-page":"11315","DOI":"10.1039\/C5OB01843A","article-title":"Arginine analogues incorporating carboxylate bioisosteric functions are micromolar inhibitors of human recombinant DDAH-1","volume":"13","author":"Tommasi","year":"2015","journal-title":"Org. Biomol. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2025.118013_bib213","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3390\/molecules27031017","article-title":"Pharmacokinetic Characterization of the DDAH1 Inhibitors ZST316 and ZST152 in Mice Using a HPLC-MS\/MS Method","volume":"27","author":"Mangoni","year":"2022","journal-title":"Molecules"},{"issue":"24","key":"10.1016\/j.biopha.2025.118013_bib214","doi-asserted-by":"crossref","first-page":"8056","DOI":"10.3390\/molecules28248056","article-title":"Development of a HPLC-MS\/MS Method to Assess the Pharmacokinetics and Tumour Distribution of the Dimethylarginine Dimethylaminohydrolase 1 Inhibitors ZST316 and L-257 in a Xenograft Model of Triple-Negative Breast Cancer in Mice","volume":"28","author":"Ceruti","year":"2023","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.biopha.2025.118013_bib215","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1021\/acscombsci.8b00133","article-title":"Novel Cellularly Active Inhibitor Regresses DDAH1 Induced Prostate Tumor Growth by Restraining Tumor Angiogenesis through Targeting DDAH1\/ADMA\/NOS Pathway","volume":"21","author":"Reddy","year":"2019","journal-title":"Acs Comb. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2025.118013_bib216","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/cmdc.201300557","article-title":"Developing an irreversible inhibitor of human DDAH-1, an enzyme upregulated in melanoma","volume":"9","author":"Wang","year":"2014","journal-title":"ChemMedChem"},{"issue":"11","key":"10.1016\/j.biopha.2025.118013_bib217","doi-asserted-by":"crossref","first-page":"19634","DOI":"10.3390\/ijms151119634","article-title":"OCT4 expression and vasculogenic mimicry formation positively correlate with poor prognosis in human breast cancer","volume":"15","author":"Liu","year":"2014","journal-title":"Int J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2025.118013_bib218","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/ijc.10423","article-title":"Vasculogenic mimicry and pseudo-comedo formation in breast cancer","volume":"99","author":"Shirakawa","year":"2002","journal-title":"Int J. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2025.118013_bib219","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3892\/ol.2014.2059","article-title":"STAT3, p-STAT3 and HIF-1alpha are associated with vasculogenic mimicry and impact on survival in gastric adenocarcinoma","volume":"8","author":"Song","year":"2014","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.biopha.2025.118013_bib220","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s11060-013-1077-7","article-title":"Vasculogenic mimicry is a prognostic factor for postoperative survival in patients with glioblastoma","volume":"112","author":"Wang","year":"2013","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.biopha.2025.118013_bib221","first-page":"1097","article-title":"Vasculogenic mimicry: a pivotal mechanism contributing to drug resistance in antiangiogenic therapy","volume":"10","author":"Dang","year":"2024","journal-title":"Oncol. Transl. Med."},{"issue":"3","key":"10.1016\/j.biopha.2025.118013_bib222","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41416-024-02722-7","article-title":"The in vitro dynamics of pseudo-vascular network formation","volume":"131","author":"Oraiopoulou","year":"2024","journal-title":"Br. J. Cancer"},{"issue":"12","key":"10.1016\/j.biopha.2025.118013_bib223","article-title":"Vascular co-option and vasculogenic mimicry mediate resistance to antiangiogenic strategies","volume":"5","author":"Pezzella","year":"2022","journal-title":"Cancer Rep. (Hoboken)"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225002070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225002070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T22:59:55Z","timestamp":1781823595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225002070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":223,"alternative-id":["S0753332225002070"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118013","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current knowledge on the mechanisms underpinning vasculogenic mimicry in triple negative breast cancer and the emerging role of nitric oxide","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118013"}}